Universal Implications of DES
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.
Overview
In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Digital Therapeutics Clinical Trials: From Design to Data Interpretation
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Personalizing Care Within the RCC Treatment Paradigm
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Understanding hypertrophic cardiomyopathy and recent guidelines
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?